GeneDx Holdings Corp. Annual Nonoperating Income (Expense) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
GeneDx Holdings Corp. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2023.
  • GeneDx Holdings Corp. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$18.8M, a 499% decline year-over-year.
  • GeneDx Holdings Corp. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$25.5M, a 176% decline year-over-year.
  • GeneDx Holdings Corp. annual Nonoperating Income (Expense) for 2023 was $3.9M, a 94.4% decline from 2022.
  • GeneDx Holdings Corp. annual Nonoperating Income (Expense) for 2022 was $69.6M, a 65.3% decline from 2021.
  • GeneDx Holdings Corp. annual Nonoperating Income (Expense) for 2021 was $201M, a 30597% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.9M -$65.7M -94.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-23
2022 $69.6M -$131M -65.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-23
2021 $201M +$200M +30597% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $654K -$55K -7.76% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 $709K Jan 1, 2019 Dec 31, 2019 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.